GlassScriptPhysician profile
Ashley Wodecki Tipper
NPI 1629563945
$23,134.10
in general payments reported to CMS, 2019-2025
57 companies · $4,651 in 2025
The $4,651 reported for 2025 was more than what 98% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,592 · 2022: $4,295 · 2023: $5,312 · 2024: $5,285 · 2025: $4,651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $376 · Entertainment: $13.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,857.27 |
| Education | $376.32 |
| Entertainment | $13.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $3,699.16 | 2021-2025 | Enbrel, Otezla, Tavneos |
| Abbvie INC. | $3,015.48 | 2021-2025 | |
| Janssen Biotech, INC. | $2,008.05 | 2021-2025 | Tremfya, Simponi Aria, Remicade |
| Novartis Pharmaceuticals Corporation | $1,534.94 | 2021-2025 | |
| Ucb, INC. | $1,160.96 | 2021-2025 | Cimzia, Bimzelx |
| Pfizer INC. | $1,159.77 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,044.34 | 2021-2025 | Saphnelo, Airsupra |
| Ani Pharmaceuticals, INC. | $925.83 | 2022-2025 | Purified Cortrophin Gel |
| Boehringer Ingelheim Pharmaceuticals, INC. | $805.68 | 2021-2025 | Ofev, Cyltezo |
| Glaxosmithkline, LLC. | $793.41 | 2021-2025 | Benlysta |
| Radius Health, INC. | $769.80 | 2021-2025 | Tymlos |
| Lilly USA, LLC | $729.28 | 2021-2025 | Taltz, Zepbound |
| Mallinckrodt Hospital Products INC. | $728.54 | 2021-2025 | Acthar |
| E.R. Squibb & Sons, L.L.C. | $482.18 | 2021-2025 | Orencia |
| Genzyme Corporation | $457.57 | 2021-2025 |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $445.74 | 2022-2025 | Xtampza, Belbuca |
| Aurinia Pharma U.S., INC. | $362.26 | 2021-2025 | Lupkynis |
| Tersera Therapeutics LLC | $325.76 | 2021-2025 | Quzyttir |
| Genentech USA, INC. | $308.39 | 2021-2025 | Actemra, Gazyva, Rituxan |
| Fresenius Kabi USA, LLC | $301.73 | 2023-2025 | Idacio |
| Horizon Therapeutics Plc | $236.38 | 2021-2023 | Krystexxa |
| Sandoz INC. | $134.43 | 2023-2025 | Hyrimoz, Jubbonti |
| Scilex Pharmaceuticals INC. | $130.21 | 2023-2025 | Ztlido |
| Kiniksa Pharmaceuticals International, Plc | $123.35 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $120.45 | 2021-2022 | |
| Sobi, INC | $102.01 | 2021-2025 | |
| Organon LLC | $95.76 | 2022-2024 | Renflexis |
| Alexion Pharmaceuticals, INC. | $90.15 | 2023-2024 | Strensiq |
| Octapharma USA, INC. | $81.00 | 2021-2025 | Octagam Immune Globulin (Human) |
| Shield Therapeutics INC | $73.50 | 2024 | |
| Abbott Laboratories | $72.41 | 2021-2025 | Eterna, Freestyle Libre 3 |
| Medtronic, INC. | $70.35 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $67.68 | 2021-2023 | Relistor |
| Bioventus LLC | $66.68 | 2021-2025 | Durolane, Gelsyn-3 |
| Daiichi Sankyo INC. | $65.72 | 2021-2022 | |
| Saluda Medical Americas, INC. | $56.38 | 2023 | Evoke Scs |
| Grt US Holding, INC. | $52.71 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $51.43 | 2025 | |
| Biodelivery Sciences International, INC. | $38.97 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $35.19 | 2021 | |
| Exact Sciences Corporation | $31.87 | 2023 | Cologuard Collection Kit |
| Tonix Medicines, INC. | $30.66 | 2025 | Tonmya |
| Otsuka America Pharmaceutical, INC. | $23.74 | 2024 | Rexulti |
| Esperion Therapeutics, INC. | $23.02 | 2021 | |
| Edwards Lifesciences Corporation | $22.92 | 2021 | |
| Insmed, INC. | $21.45 | 2024 | Arikayce |
| Kiniksa Pharmaceuticals, LTD. | $18.47 | 2023 | Arcalyst |
| Novo Nordisk INC | $16.39 | 2022 | |
| Hikma Pharmaceuticals USA | $16.36 | 2022 | |
| Spinal Simplicity, LLC | $15.47 | 2022 | |
| Invivyd INC | $15.02 | 2025 | Pemgarda |
| Virtus Pharmaceuticals LLC | $14.42 | 2025 | Levorphanol Tartrate |
| Optos, INC. | $13.49 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Lundbeck LLC | $12.98 | 2023 | Vyepti |
| Biohaven Pharmaceutical Holding Company LTD. | $12.82 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.82 | 2022 | |
| Forte Bio-Pharma LLC | $9.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Tipper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.